Buochs (ots) - DG-Nika AG – a new approach to therapy & proactive protection from the pandemic The corona pandemic continues to pose a global threat: To date, it has been possible to vaccinate only a small fraction of the total population. On top of that, there is acute danger from mutations of this virus. Against this backdrop, the DG-Nika AG research team has developed a solution for a new approach to protecting the ...
Information Office of Beijing Municipal Government
Vienna (ots) - In partnership with local distributor DIVISIONCARE, tFRWD is ready to supply large numbers of the test-kits to the Portuguese. The test is done through RT.PCR and the kit is CE certified and approved by WHO with a sensitivity / specificity of 99%. This is the first Covid19 self-test solution to perform at home, completely painless, and without needing a health professional to collect the sample. Tester ...
Moers (ots) - Whether it’s a lung embolism or a heart attack – an infection with coronavirus can have life-threatening consequences. But how badly will different patients be affected by COVID-19? This can be determined by certain biomarkers. nal von minden GmbH’s biomarker rapid tests from Germany deliver reliable results in just 15 minutes. An infection with ...
Technische Universität München
Corporate Communications Center phone: +49 8161 5403 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36345/ NEWS RELEASE On the trail of the genetic code Overlapping gene found in SARS-CoV-2 Viruses are infectious organic structures that spread by transmission and can only multiply within a ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22562 - email: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/36263/ NEWS RELEASE How the virus enters the cell Coronavirus: Neuropilin-1 could open the door to the inside of the cell The protein neuropilin-1 facilitates SARS CoV-2 cell entry. A research team including ...
Helsinki (ots) - The Finnish Koronavilkku ('Corona Blinker') application, which helps to break chains of coronavirus infection, has already been downloaded over 2 million times. The milestone of 2 million downloads - 37 % of the population - was reached two weeks after the application became available for download in app stores. 'We all now have a genuine opportunity ...
Foreign office of Kazakhstani opposition
Dr. Rath Education Services BV
Vodafone Institut für Gesellschaft und Kommunikation GmbH
Berlin (ots) - - Vodafone Institute poll "Digitising Europe Pulse" across 13 EU member states - People across Europe feel that they are well equipped digitally at home to meet current challenges. Best scores in Germany and Portugal - The majority of EU citizens consider measures of the Federal Government on COVID-19 ...
Visbek, Germany (ots) - IgNova announced today that it has filed a patent application covering the use of passive immunization to control SARS-CoV-2 infection in humans. IgNova, a biopharmaceutical R&D start up, researches technology based on specific egg immunoglobulins (IgY). The patented IgY binds the spike protein of SARS-CoV-2, neutralizing the virus when it enters the mouth or nose and, therefore, inhibiting the ...
Scottsdale (ots) - Win for Proctorio and online education as a whole. Students of UvA and other similar universities can now continue their education from their own home without sacrificing integrity or the validity of the degrees they earned. With the rapid spread of COVID-19, universities all over the world have been forced to transfer their physical learning ...
Mediaform Informationssysteme GmbH
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through ...
Hamburg (ots) - Fielmann has acted early and decidedly, as the coronavirus pandemic spread across Europe. On the basis of a scientific study by Prof. Dr. med. Dr. h.c. Martin Exner (University Hospital Bonn), the company has defined hygiene standards that counter the infection risks of COVID-19. According to these ...
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 8161/ 71-3207 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35999/ High resolution images: https://mediatum.ub.tum.de/1544195 In the hunt for new treatments against the coronavirus Researchers develop software for drug repurposing Currently, the corona pandemic is ...
